We reiterate that although PepsiCo (PEP) has been a poor performing company under the mismanagement of Indra Nooyi, it is still an industry leading beverage maker. We're displeased that PepsiCo's gains against Coca-Cola (KO) under her mentor Steven Reinemund have dissipated under her watch. Despite the mediocre performance and recent growth by acquisition strategy, we're still not comfortable shorting it. With Nelson Peltz backing PepsiCo, Warren Buffett's Berkshire Hathaway [(BRK.A) (BRK.B)] backing Coca-Cola and Don Yacktman backing both beverage makers, we can see that institutional investors are providing support for these firms. We maintain that the company's dividend and share repurchase program is providing additional support for the shares and we believe that it is merely a fairly valued company that will not repeat its outperformance against the S&P 500 that it enjoyed since the 1980s. We believe that the same paradigm also applies to Coca-Cola, albeit to a slightly smaller extent. That doesn't change the fact that Coca-Cola has a forward PE of 17.1 and a consensus LTG of 8.8% and PepsiCo has a forward PE of 18.6 and a consensus LTG of 8.5%.
Hot Freight Companies To Own For 2015: Remy Cointreau SA (RCO)
Remy Cointreau SA is a France-based company engaged in the production and distribution of wines and spirits. The Company's activities are divided into two segments. Cognac, which offers a range of products under the Remy Martin brand and Liqueurs and Spirits, distributing liquors under the Cointreau, Izarra and Passoa brand names, as well as spirits under such brand names as Mount Gay (rum), St Remy (brandy), Ponche Kuna (rum) and Metaxa (brandy). The Company is a sole distributor of the Piper-Heidsieck and Charles Heidsieck brands, as well as Piper Sonoma (the sparkling wine brand). The Company's subsidiaries include production companies, such as E. Remy Martin & Cie, and distribution companies, such as Remy Cointreau USA Inc. In August 2013, it completed the sale of Larsen Cognac to the Finnish group Altia. Advisors' Opinion:- [By Inyoung Hwang]
Remy Cointreau SA (RCO) jumped 6 percent, the most since January. Chinese cognac shipments increased 20.5 percent in August, rising for the first time since January, according to UBS AG, citing from BNIC, a trade association of cognac makers.
- [By Jonathan Morgan]
European stocks dropped, following a two-day gain, as Remy Cointreau SA (RCO) and Pernod Ricard SA dragged food-and-beverage makers lower. U.S. index futures and Asian shares were little changed.
Top 10 Performing Companies To Buy For 2014: Sterling Consolidated Corp (STCC)
Sterling Consolidated Corp., incorporated on January 31, 2011, is a holding company. The Company�� operations are conducted through its four subsidiaries: Sterling Seal & Supply, Inc. (Sterling Seal), ADDR Properties, LLC (ADDR), Q5 Ventures, LLC (Q5), and Integrity Cargo Freight Corporation (Integrity). The Company through its subsidiary, Sterling Seal engages primarily in the distribution and sale of O-rings, rubber seals, oil seals, custom molded rubber parts, custom Teflon parts, Teflon rods, O-ring cord, bonded seals, O-ring kits, and stuffing box sealant. The Company also owns real property through its subsidiaries ADDR and Q5. In addition, the Company�� subsidiary Integrity Cargo Freight Corporation (Integrity) is a freight forwarding business. In September 2013, the Company announced the acquisition of Superior Seals and Service in High Point, NC.
Sterling Seal sells directly to smaller distributors and original equipment manufacturers in need of seals. It offers a catalogue of standard sizes, and will take orders for special sizes not available in the standard catalogue. O-rings and the other products that Sterling Seal sells are used in a variety of industries, including automotive, pump, transmissions, oil and energy, machinery, and packaging. Integrity are primarily responsible for transporting products the Company order from its suppliers back to its warehouse in Neptune, NJ. After Sterling Seal confirms from its supplier that a product is ready to be picked up, Integrity Cargo is responsible for picking up the products and getting them to the dock and delivered to the Sterling Seal warehouse. ADDR owns a 28,000 square foot facility in Neptune, NJ. Q5 Ventures, LLC owns a 5,000 square foot facility in Apopka, Florida, which is used by Sterling Seal for its Florida operations.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Muscle Warfare International (OTCMKTS: MWAR), Portlogic Systems Inc (OTCMKTS: PGSY) and Sterling Consolidated Corp (OTCBB: STCC) were all the subject of a few paid promotions as recently as last week but they sure did not start the new week out right because all were sinking on Monday. So are these small cap stocks that are either the subject of promotions or investor awareness campaigns hot or not? Here is a quick reality check:
- [By Peter Graham]
Small cap stocks Pulse Network Inc (OTCBB: TPNI), Sterling Consolidated Corp (OTCBB: STCC) and diaDexus, Inc (OTCMKTS: DDXS) have or could start to sizzle for investors. However, I should also mention that two of these stocks have been the subject of paid promotions while a third apparently has not been, and could be the real deal. With that in mind, here is a closer look along with a quick reality check about all three small caps to help you decide whether they are hot or not:
Top 10 Performing Companies To Buy For 2014: International Montoro Resources Inc (IMT)
International Montoro Resources Inc. is engaged in the exploration and development of mineral properties, focusing on projects in British Columbia, Saskatchewan, and Ontario, Canada. The Company holds a 100% interest in the Malachite Project (New Brunswick). The Company holds a 50% interest in the Red Lake Project (Ontario), the Malachite property consists of 62 claim units comprising 1,352.25 hacteres. The Crackingstone River Project (Saskatchewan) consists of 750 hectare claim block in northern Saskatchewan near Uranium City. The Cup Lake/Donen Claims located in the Greenwood Mining District of B.C. On May 24, 2012, the Company acquired a 100% interest in four mineral claims representing 1,065.10 hactares, which were located in the middle of the west side of the Tacheeda Lake claim block. Advisors' Opinion:- [By Namitha Jagadeesh]
British American Tobacco Plc and Imperial Tobacco Group Plc (IMT) each lost at least 1.5 percent as American peer Philip Morris International Inc. forecast 2014 profit growth below its long-term target. Antofagasta Plc (ANTO) and Vedanta Resources Plc (VED) followed miners lower, sliding at least 2 percent. Johnson Matthey Plc (JMAT) gained 3.9 percent after posting better-than-forecast profit and raising its dividend.
Top 10 Performing Companies To Buy For 2014: Pacira Pharmaceuticals Inc.(PCRX)
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, commercialization, and manufacture of pharmaceutical products for use in hospitals and ambulatory surgery centers. The company develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. Its product portfolio includes EXPAREL, a long-acting non-opioid postsurgical analgesic for postsurgical pain management; DepoCyt for the treatment of lymphomatous meningitis, a cancer of the immune system; DepoDur for controlling post operative pain; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate that is in preclinical trials for the treatment of rheumatoid arthritis oncology. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Monday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Nordion (NYSE: NDZ) and Pacira Pharmaceuticals (NASDAQ: PCRX). Utilities sector rose by just 0.19 percent in the US market today. - [By STOCKPICKR]
Pacira Pharmaceuticals (PCRX) is an emerging specialty pharmaceutical company engaged in development, commercialization and manufacture of proprietary pharmaceutical products for use in hospitals and ambulatory surgery centers. This stock closed up 12.5% at $55.93 in Monday's trading session.
Monday's Volume: 944,000
Three-Month Average Volume: 517,152
Volume % Change: 80%
From a technical perspective, PCRX exploded higher here back above its 50-day moving average of $52.50 with above-average volume. This stock recently formed a double bottom chart pattern at $46.55 to $47.21. Since forming that bottom, shares of PCRX have started to rip higher and move within range of triggering a major breakout trade. That trade will hit if PCRX manages to take out Monday's intraday high of $56 to its 52-week high at $56.94 with high volume.
Traders should now look for long-biased trades in PCRX as long as it's trending above its 50-day at $52.20 and then once it sustains a move or close above those breakout levels with volume that's near or above 517,152 shares. If that breakout hits soon, then PCRX will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $60 to $63.
A.M. Castel
A.M. Castel (CAS) is a specialty metals and plastics distribution company. Its core products include nickel alloys, aluminum, stainless steel and carbon in various forms, such as plate, bars, tubing and coil. This stock closed up 9% at $14.88 in Monday's trading session.
Monday's Volume: 487,000
Three-Month Average Volume: 156,083
Volume % Change: 204%
From a technical perspective, CAS gapped sharply higher here back above its 50-day moving average of $14.27 and into breakout territory above some near-term overhead resistance at $14.37 with strong upside volume. This move pushed shares of CAS out of its downtre
- [By Seth Jayson]
Pacira Pharmaceuticals (Nasdaq: PCRX ) is expected to report Q1 earnings on May 8. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Pacira Pharmaceuticals's revenues will increase 69.4% and EPS will remain in the red. - [By John Udovich]
Bubble talk, biotech IPO setbacks plus news�about small cap biotechs like Intrexon Corp (NYSE: XON) and TNI BioTech (OTCMKTS: TNIB) have dominated biotech news this week or in recent weeks. Just consider the following news:
Why There is No Biotech Bubble & Where to Look for Value in Biotech. Marshall Gordon, the Director and senior health-care analyst of ClearBridge Investments, was recently interviewed by Barron�� where he stated his belief that there is no biotech bubble because biotech stocks have delivered new drugs and have shown an ability to innovate. With that said, he added that the sector got ahead of itself while some biotechs suffered setbacks plus hedge funds decided to trim risk from their portfolios. Nevertheless, Marshall likes or is watching mid cap biotechs BioMarin Pharmaceutical Inc (NASDAQ: BMRN) and Pharmacyclics, Inc (NASDAQ: PCYC) along with small cap biotechs�Pacira Pharmaceuticals Inc (NASDAQ: PCRX) and Clovis Oncology Inc (NASDAQ: CLVS). He also added that recent biotech IPOs have been lesser quality names than earlier offerings. A Trio of Biotech�IPO Setbacks. FierceBiotech has�summarized how a trio of biotech IPO have suffered setbacks. Specifically, Relypsa (NASDAQ: RLYP), a late-stage biotech developing a treatment for hyperkalemia,�slashed its asking price on 6.9 million shares to $12 a share to raise $82 million�from a range of $16 to $19 a share while�Xencor (NASDAQ: XNCR), a biotech developing antibodies for severe autoimmune/allergic diseases and cancer,�has dropped its IPO price to $7 a share to raise $75 million from a range of $14 to $16. Meanwhile, Celladon, which is developing a first-in-class gene therapy for patients with systolic heart failure, has postponed its IPO citing poor market conditions. Coming�Biotech IPOs. Nevertheless, FierceBiotech has noted that GeNO Healthcare (NASDAQ: GNO) is looking to raise $50 million for its�new, patient-friendly approach for delivering inhaled nitric oxide on the
Top 10 Performing Companies To Buy For 2014: Spdr Dj Wilshire Small Cap Etf (SLY)
SPDR DJ Wilshire Small Cap ETF (the Fund), formerly streetTRACKS DJ Wilshire Small Cap ETF, seeks to replicate as closely as possible the total return of the Dow Jones Wilshire Small Cap Index (the Index). The Index is a float-adjusted market capitalization weighted index that reflects the shares of securities of the small-cap portion of the Dow Jones Wilshire 5000 Composite Index actually available to investors in the marketplace. The Index includes the components ranked 751 to 2,500 by full market capitalization. The Index consists of common stocks selected for their capitalization. The composition of the Index is reviewed semiannually in March and December. Shares and float factors of the Index are updated on a quarterly basis.
The Fund utilizes a passive or indexing approach and attempts to approximate the investment performance of its Index, by investing in a portfolio of stocks intended to replicate the Index. The Fund�� investment manager is SSgA Funds Management, Inc.
Advisors' Opinion:- [By Dan Caplinger]
Where the best gains are
The SPDR S&P 500 ETF (NYSEMKT: SPY ) weighs in with 20% gains with its exposure to 500 of the largest companies in the U.S. market. When you step down to mid-cap stocks, though, you'll get even better returns, with the SPDR S&P MidCap 400 ETF (NYSEMKT: MDY ) posting returns of 21% so far in 2013, based on the performance of 400 mid-sized companies domestically. The smallest companies in the market have done better still, as the SPDR S&P SmallCap 600 ETF (NYSEMKT: SLY ) has given investors impressive 24% returns since Jan. 1.
In fact, when you compare returns across stocks of various sizes, you'll get some surprising results:Why are smaller companies outperforming the largest stocks in the market? Historically, smaller stocks have posted better long-term returns than their larger counterparts, with theoreticians pointing to the greater risk involved in small-cap stocks as justifying the higher risk premium that investors should demand in order to hold them over the long run.
- [By Will Ashworth]
By the time the dust settled in 2013, small caps won the day (well, year) — the SPDR S&P SmallCap 600 (SLY) had outperformed the SPDR S&P 500 ETF (SPY) by almost 9 percentage points.
Top 10 Performing Companies To Buy For 2014: China Life Insurance Company Limited(LFC)
China Life Insurance Company Limited provides life, annuities, accident, and health insurance products in China. Its individual life insurance and annuity products consist of whole life and term life insurance, endowment insurance, and annuities. The company also engages in the writing of life insurance business. In addition, it offers group life insurance products, including group annuity products, and group whole life and term life insurance products to enterprises and institutions, as well as universal life products. Further, the company provides short-term insurance products comprising short-term accident insurance and short-term health insurance products; accident insurance products, such as individual accident insurance and group accident insurance; and health insurance products, including defined health benefit plans, medical expense reimbursement plans, and disease specific plans. It distributes its products through its direct sales representatives and exclusive ag ents, as well as through intermediaries comprising insurance agencies and insurance brokerage companies, non-dedicated agencies, bancassurance arrangements, travel agencies, and hotels and airline sales counters. The company was founded in 1949 and is based in Beijing, China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company.
Advisors' Opinion:- [By John Udovich]
China is set to ease the one child policy, something that could benefit Chinese stocks in general but be especially beneficial to insurance stocks like China Life Insurance Company Ltd (NYSE: LFC) and CNinsure Inc (NASDAQ: CISG) plus health care stocks like Mindray Medical International Ltd�(NYSE: MR) and Concord Medical Services Hldg Ltd (NYSE: CCM). First, let�� be clear that China is NOT abolishing the one child policy as the changes will merely�allow married couples to have two children if one spouse is an only child plus it will be up to China�� 34 province-level administrations to revise�their laws and put the new policy into effect. Moreover, China�� family-planning bureaucracy employs more than 500,000 full-time workers and six million part-time workers all the way down to the village level to�collect billions of dollars in fines and these bureaucrats have fought for years against policy changes���meaning they could throw up roadblocks if not placated. With that said, the insurance and health care sectors are two sectors with publicly Chinese stocks that look set to�take advantage of the coming changes.
- [By Vanin Aegea]
I have heard many people comment about the insurance policies for cars, houses, life, assets, etc. The arguments always revolve around the same issue: Is it really necessary? What are the chances to be hit by a Hurricane, or to meet a sudden death? Well, nobody really knows. Some individuals however, sleep better when they know a policy backs their life investments. Here, I will look into three insurance companies that concentrate on different policies, or geographies. These are: China Life (LFC), and Conseco (CNO).
Top 10 Performing Companies To Buy For 2014: Templeton Emerging Markets Fund (EMF)
Templeton Emerging Markets Fund (the Fund) is a diversified, closed-end investment company. The Fund seeks long-term capital appreciation by investing at least 80% of its net assets in emerging country equity securities. It makes investments in China, Brazil, South Korea, Turkey, Russia, Thailand, India, Taiwan, Hungary and South Africa. The Fund invests in sectors, such as metals and mining, commercial banks, diversified financial services, semiconductors and semiconductor equipment, wireless telecommunication services, and oil, gas and consumable fuels.
Templeton Asset Management Ltd. (TAML) serves as the Fund�� investment manager. Its administrative manager is Franklin Templeton Services, LLC. The Fund may invest in the Franklin Institutional Fiduciary Trust Money Market Portfolio (the Sweep Money Fund), an open-end investment company managed by Franklin Advisers, Inc. (an affiliate of TAML).
Advisors' Opinion:- [By George Putnam, Editor, New Generation Research, Inc.]
Templeton Emerging Markets Fund (EMF) is also actively managed. Currently, the fund is Asian-centric with about 71% of assets from Asian markets, mostly China and Thailand.
No comments:
Post a Comment